Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2007-2016

  Zou, Changping ^a,e   Zhou, Jianwei ^b   Qian, Linxin ^b   Feugang, Jean M ^a   Liu, Jia ^b   Wang, Xinru ^b   Wu, Sheng ^b   Ding, Hong ^b   Zou, Changchun ^a   Liebert, Monica ^c   Grossman, H Barton ^d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c American Urology Association   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

4 HPR; ATRA; Bladder Cancer; CD437; JWA Retinoid Response Gene; Neoplasia; Retinoids; Tumor; Urinary tract

Indexed keywords

EID: 33744762793     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1942     Document Type: Article

References (48)

1. Alfthan, O., Tarkkanen, J., Grohn, P., Heinonen, E., Pyhonen, S., and Saila, K. Tigason (Etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind Clinical trial. Eur Urol 9, 6-9 (1983)
2. Ross, R. K., Paganini-Hill, A., and Henderson, B. E. Epidemiology of bladder cancer. In: Skinner D, Lieskovsky G (eds). Diagnosis and Management of Genitourinary Cancer. Philadelphia:Saunders and Co. pp 23-31 (1988)
3. Kelloff, G. J., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A., Greenwald, P., Alberts, D. S., Covey, J. M., Doody, L. A., and Knapp, G. G. N-(4-hydroxyphenyl)retinamide (4-HPR): Clinical development plan. J Cell Biochem 20, 176-196 (1994)
4. Modiano, M. R., Dalton, W. S., Lippman, S. M., Joffe, L., Booth, A. R., and Meyskens, F. L. Jr. Phase II study of fenretinide N-(4-hydroxyphenyl] retinamide in advanced breast cancer and melanoma. Invest. New Drugs 8, 317-319 (1990)
5. Pollard, M., Luckert, P. H., and Sporn, M. B. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl) retinamide. Cancer Res 51, 3610-3611 (1991)
6. Decensi, A., Bruno, S., Giaretti, W., Torrisi, R., Curotto, A., Gatteschi, B., Geido, E., Polizzi, A., Costantini, M., Bruzzi, P., Nicolo, G., Costa, A., Boccardo, F., Giuliani, L., and Santi, L. Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint. J Cell Biochem 161, 139-147 (1992)
7. Tradati, N., Chiesa, F., Rossi, N., Grigolato, R., Formeli, F., Costa, A., and De Palo, G. Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett 76, 109-111 (1994)
8. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF 1, a potential mediator of p53 tumor suppression. Cell 75, 817-823 (1993)
9. Pfahl, M., and Piedrafita, F. J. Retinoid targets for apoptosis induction. Oncogene 22, 9058-62 (2003)
10. Kim, H. J., and Lotan, R. Identification of protein modulation by the synthetic retinoid CD437 in lung carcinoma cells using high throughput immunoblotting. Int J Oncol 26, 483-91 (2005)
11. Keedwell, R. G., Zhao, Y., Hammond, L. A., Qin, S., Tsang, K. Y., Reitmair, A., Molina, Y., Okawa, Y., Atangan, L. I., Shurland, D. L., Wen, K., Wallace, D. M., Bird, R., Chandraratna, R. A., and Brown, G. A retinoid-related molecule that does not bind to classical retinoid receptors potently induces apoptosis in human prostate cancer cells through rapid caspase activation. Cancer Res 64, 3302-12 (2004)
12. Joseph, B., Marchetti, P., Lefebvre, O., Schraen-Maschke, S., Mereau-Richard, C., and Formstecher, P. The novel retinoid AHPN/CD437 induces a rapid but incomplete apoptotic response in human myeloma cells. Biochim Biophys Acta 1593, 277-82 (2003)
13. Holmes, W. F., Soprano, D. R., and Soprano, K. J. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines. J Cell Physiol 199, 317-29 (2004)
14. Zhang, Y., Dawson, M. I., Mohammad, R., Rishi, A. K., Farhana, L., Feng, K. C., Leid, M., Peterson, V., Zhang, X. K., Edelstein, M., Eilander, D., Biggar, S., Wall, N., Reichert U., and Fontana, J. A. Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog. Blood 100, 2917-2925 (2002)
15. Zhang, X. K. Vitamin A and apoptosis in prostate cancer. Endocr Relat Cancer 9, 87-102 (2002)
16. Lotan, R. Receptor-independent induction of apoptosis by synthetic retinoids. J Biol Regul Homeost Agents 17, 13-28 (2003)
17. Kumar, A., Soprano, D. R., Parekh, H. K. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res 61, 7552-7555 (2001)
18. Lotan, R., and Clifford, J. L. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. Biomed Pharmacother 45, 145-56 (1990)
19. Chambon, P. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5, 115-25 (1994)
20. DeLuca, L. M. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 5, 2924-3033 (1991)
21. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. "The retinoid receptors". In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.). The Retinoids. New York:Raven Press. 319-349 (1994)
22. Pfahl, M. Vertebrate receptors: molecular biology, dimerization and response elements. Semin Cell Biol 5, 95-103 (1994)
23. Jianwei Zhou. GenBank: AF070523 (1998)
24. Xia, W., Zhou, J., Cao, H., Zou, C., Wang, C., Shen, Q., and Lu, H. The relationship between structure and function of JWA in the modulation of cell differentiation. Chinese Sci Bull 46, 2063-2067 (2001)
25. Cao, H., Xia, W., Shen, Q., Lu, H., Ye, J., Li, A., Zou, C. P., and Zhou, J. The role of JWA in acute promyelocytic leukemia cell differentiation and apoptosis triggered by retinoic acid, 12-tetradecanoylphorbol-13-acetate and arsenic trioxide. Chinese Sci Bull 47, 834-838 (2002)
26. Zou, C. P., Liebert, M., Zou, C. C., Grossman, H. B., and Lotan, R. Identification of effective retinoids for inhibition growth and inducing apoptosis in bladder cancer cells. J Urol 165, 986-992 (2001)
27. Studer, U. E., Biedermann, C., Chollet, D., Karrer, P., Kraft, R., Toggenbutg, H., Vonbank, F. Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicenter trial in Switzerland. J Urol 131, 47-9 (1984)
28. Prout, G. R., Barton, B. A. 13-cis-retinoic acid in chemoprevention of superficial bladder cancer. J Cell Biochem Suppl 161, 148-152 (1992)
29. Liu, Y., Lee, M.-C., Wang, H., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C., and Zhang, X.-K. Retinoid acid receptor b mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16, 1138-1149 (1996)
30. Osone, S., Hosoi, H., Kuwahara, Y., Matsumoto, Y., Iehara, T., and Sugimoto, T. Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells. Int J Cancer 112, 219-224 (2004)
31. Dmitrovsky, E. Fenretinide activates a distinct apoptotic pathway. Fenretinide activates a distinct apoptotic pathway. J Natl Cancer Inst 96, 1264-1265 (2004)
32. Hail, N. Jr., and Lotan, R. Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl) retinamide. J Biol Chem 276, 45614-45621 (2001)
33. Sidransky, D. Clinical implications of the p53 gene. Annu Rev Med 47, 285-301 (1996)
34. Sidransky, D., Frost, P., Von Eschenbach, A., Oyasu, R., Preisinger, A. C., Vogelstein, B. Clonal origin bladder cancer. N Engl J Med 326, 737-740 (1992)
35. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. P53 mutations in human cancers. Science 253, 49-53 (1991)
36. Cordon-Cardo, C., Dalbagni, G., Saez, G. T., Oliva, M. R., Zhang, Z.-F., Rosai, J., Reuter, V., and Pellicer, A. p53 mutation in human bladder cancer: genotypic versus phenotypic patterns. Intl J Cancer 56, 347-353 (1994)
37. Lutzker, S. G., and Levine, A. J. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat Med 2, 804-810 (1996)
38. Okazawa, H., Shimizu, J., Kamei, M., Imafuku, I., Hamada, H., and Kanazawa, I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal carcinoma stem cells. J Cell Biol 132, 955-968 (1996)
39. Davidoff, A. M., Pence, J. C., Shorter, N. A., Igelhart, J. D., and Marks, J. R. Expression of p53 in human neuroblastoma- and neuroepithelioma- derived cell lines. Oncogene 7, 127-133 (1992)
40. Maxwell, S. A., and Mukhopadhyay, T. Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid. Exp Cell Res 214, 67-74 (1994)
41. Okazawa, H., Shimizu, J., Kamei, M., Imafuku, I., Hamada, H., and Kanazawa, I. (1996) Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal carcinoma stem cells. J Cell Biol. 132, 955-968.
42. Kazmi, M. I. S., Plante, R. K., Visconti, V., and Lau, C. Y. Comparison of N-(4-hydroxyphenyl) retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res 56, 1056-1062 (1996)
43. Holmes W. F., Soprano D. R., Soprano K. J. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines. J Cell Physiol 199(3), 317-329 (2004)
44. Zhang X. K. Vitamin A and apoptosis in prostate cancer. Endocr Relat Cancer 9, 87-102 (2002)
45. Hsieh, T. C., Ng C., and Wu, J. M. The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells. Biochem Mol Biol Int 37, 499-506 (1995)
46. Zou, C. P., Guan, Y., Zou, C. C., Wang, J., Wang, L. E., Liebert, M., Grossman, and Wei, Q. N-(4-hydroxyphenyl) retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines. Cancer Ltrs 180: 131-137 (2002)
47. Benito, A., Grillot, D., Nunez, G., and Fernandez-Luna, J. S. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol 146, 481-490 (1995)
48. Zou, C. P., Kurie, J. M., Lotan, D., Zou, C. C., Hong, W. K., and Lotan, R. N-(4-Hydroxyphenyl) Retinamide (4HPR) induces apoptosis in human non-small cell lung cancer (NSCLC) cell lines. Clin Cancer Res 4, 1345-1355 (1998)